CDK1 and hepatoblastoma: Increased co-expression of CCNA2 and CDK1 has been observed in hepatoblastoma, and inhibiting the expression of CCNA2 and CDK1 attenuates the proliferative, migrative, and invasive capacities of both HepG2 and HuH-6 cells [42].